Senior Media Relations Specialist

Ariane Le Chevallier

Senior Media Relations Specialist

503-494-8231

Study: Tiny bubbles, ultrasound could prevent amputations
By Ariane Le Chevallier April 17, 2017
A study published in the journal Circulation shows that injecting microbubbles into the blood streams of mice and human subjects and then performing an ultrasound on a leg can increase blood flow, which could promote healing and save limbs from amputation.
Seeing because of someone else’s eyes
By Ariane Le Chevallier March 24, 2017
Surgeons at OHSU Casey Eye Institute are using a new technique called Halo graft, a patch made of donated corneal tissue, to perform tube shunt surgeries that prevent vision loss in glaucoma patients.
The biggest risk factor for heart disease? Diabetes
By Ariane Le Chevallier March 22, 2017
Kent Thornburg, Ph.D., has taken an unconventional approach to fighting chronic disease. On any given day, you can find him evangelizing this tenet: your risk for chronic diseases such as heart disease was determined before you were even born. As part of American Diabetes Association Alert Day and National Nutrition Month, read what he has to say about the biggest threats to good nutrition and heart health.
Care received at end of life varies drastically by state
By Ariane Le Chevallier March 15, 2017
Oregonians with serious illness or frailty are more likely to have their end-of-life care wishes honored, less likely to be hospitalized, and more likely to use home hospice services than the rest of the country.
Researchers hone in on when, where Zika virus attacks
By Ariane Le Chevallier March 09, 2017
The Zika virus attacks tissues in the nervous system, male and female reproductive and urinary tracts, muscles, joints and lymph nodes, and persists for at least 35 days, according to a study conducted in a nonhuman primate model by a multidisciplinary team of researchers at OHSU in Portland, Oregon.
Updated preventive health recommendations a win for women nationwide
By Ariane Le Chevallier February 22, 2017
Physicians in the Pacific Northwest Evidence-based Practice Center at OHSU in Portland, Oregon, played a critical role in updating recommendations for the Women’s Preventive Services Guidelines, which address a wide variety of unique health issues women face.
Vaccine technology developed by OHSU scientists acquired by industry leaders
By Ariane Le Chevallier January 25, 2017
A first-of-its-kind vaccine technology platform developed by renowned scientists at OHSU in Portland, Oregon, has been acquired by Vir Biotechnology, a San Francisco-based biotech startup backed by leading industry investor ARCH Venture Partners and the Bill & Melinda Gates Foundation, a leading funder of global health initiatives.